76 related articles for article (PubMed ID: 1700271)
1. Pentoxifylline inhibition of procoagulant activity generated by activated mononuclear phagocytes.
De Prost D; Ollivier V; Hakim J
Mol Pharmacol; 1990 Oct; 38(4):562-6. PubMed ID: 1700271
[TBL] [Abstract][Full Text] [Related]
2. [Inhibition by pentoxifylline of procoagulant activity produced by endotoxin-active monocytes].
de Prost D; Ollivier V; Hakim J
C R Seances Soc Biol Fil; 1992; 186(3):186-92. PubMed ID: 1283564
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP increases endogenous granulocyte colony-stimulating factor formation in monocytes and THP-1 macrophages despite attenuated TNF-alpha formation.
Hareng L; Meergans T; von Aulock S; Volk HD; Hartung T
Eur J Immunol; 2003 Aug; 33(8):2287-96. PubMed ID: 12884304
[TBL] [Abstract][Full Text] [Related]
4. Procoagulant properties of OKT3 at the monocyte level: inhibition by pentoxifylline.
Pradier O; Abramowicz D; Capel P; Goldman M
Transplant Proc; 1993 Apr; 25(2 Suppl 1):39-40. PubMed ID: 8465421
[No Abstract] [Full Text] [Related]
5. [Effect of platelet on procoagulant activity of monocyte].
Xu J; He X; Xiong S
Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):478-80. PubMed ID: 11758230
[TBL] [Abstract][Full Text] [Related]
6. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline.
Strieter RM; Remick DG; Ward PA; Spengler RN; Lynch JP; Larrick J; Kunkel SL
Biochem Biophys Res Commun; 1988 Sep; 155(3):1230-6. PubMed ID: 2460096
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of procoagulant activity of human monocytes by chenodeoxycholic acid: involvement of protein kinase C.
Podevin P; Calmus Y; Robert A; Poupon R; Cherqui G
Hepatology; 1994 May; 19(5):1164-70. PubMed ID: 8175138
[TBL] [Abstract][Full Text] [Related]
9. Effects of prostacyclin analogs on the synthesis of tissue factor, tumor necrosis factor-alpha and interleukin-1 beta in human monocytic THP-1 cells.
Crutchley DJ; Conanan LB; Que BG
J Pharmacol Exp Ther; 1994 Oct; 271(1):446-51. PubMed ID: 7525928
[TBL] [Abstract][Full Text] [Related]
10. Induction of monocyte procoagulant activity with OKT3 antibody.
Iitaka M; Iwatani Y; Row VV; Volpé R
J Immunol; 1987 Sep; 139(5):1617-23. PubMed ID: 3114371
[TBL] [Abstract][Full Text] [Related]
11. Prostacyclin analogues inhibit tissue factor expression in the human monocytic cell line THP-1 via a cyclic AMP-dependent mechanism.
Crutchley DJ; Solomon DE; Conanan LB
Arterioscler Thromb; 1992 Jun; 12(6):664-70. PubMed ID: 1375507
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclic AMP and cyclic GMP on thromboplastin (factor III) synthesis in human monocytes in vitro.
Lyberg T
Thromb Haemost; 1983 Dec; 50(4):804-9. PubMed ID: 6320487
[TBL] [Abstract][Full Text] [Related]
13. Induction of monocyte-macrophage procoagulant activity by transformed cell lines.
Rambaldi A; Alessio G; Casali B; Passerini CG; Donati MB; Mantovani A; Semeraro N
J Immunol; 1986 May; 136(10):3848-55. PubMed ID: 3701063
[TBL] [Abstract][Full Text] [Related]
14. Discordant expression of tissue factor antigen and procoagulant activity on human monocytes activated with LPS and low dose cycloheximide.
Walsh JD; Geczy CL
Thromb Haemost; 1991 Nov; 66(5):552-8. PubMed ID: 1803619
[TBL] [Abstract][Full Text] [Related]
15. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL
Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
[TBL] [Abstract][Full Text] [Related]
16. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo.
Beshay E; Croze F; Prud'homme GJ
Clin Immunol; 2001 Feb; 98(2):272-9. PubMed ID: 11161985
[TBL] [Abstract][Full Text] [Related]
17. Recombinant IFN-gamma synergizes with lipopolysaccharide to induce macrophage membrane procoagulants.
Moon DK; Geczy CL
J Immunol; 1988 Sep; 141(5):1536-42. PubMed ID: 2457619
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of blood clotting activation in inflammation: the role of mononuclear phagocytes.
Semeraro N; Lattanzio A; Montemurro P; Papanice M; De Lucia O; De Bellis G; Giordano D
Int J Tissue React; 1985; 7(4):313-20. PubMed ID: 4066203
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13.
Osnes LT; Westvik AB; Joø GB; Okkenhaug C; Kierulf P
Cytokine; 1996 Nov; 8(11):822-7. PubMed ID: 9047078
[TBL] [Abstract][Full Text] [Related]
20. [Leukocyte procoagulant activity and chemotherapeutic agents: comparison between the effects of adriamycin and epiadriamycin on the procoagulant lympho/monocytic activity in vitro].
Capodicasa E; Corazzi F; Romagnoli M; de Bellis F; Ciaccio V; Ficola F; Bonifacio E; Villa A
Minerva Med; 1994 Nov; 85(11):569-77. PubMed ID: 7808681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
